Nmn

Lawsuit against FDA on NMN ‘certainly being considered’, says NPA CEO

Lawsuit against FDA on NMN ‘certainly being considered’, says NPA CEO

By Stephen Daniells

The Natural Products Association is hoping the US Food & Drug Administration is responsive to its recent Citizen’s Petition on the status of NMN, but if it’s not then other options are being considered, Dr Daniel Fabricant, NPA’s CEO tells NutraIngredients-USA.

©Getty Images - Ildo Frazao

FDA’s takedown of NMN raises fairness, transparency concerns

By Hank Schultz

NMN, an anti-aging ingredient, has been disallowed by FDA because of its prior investigation as a drug. The determination, which came as something of a surprise given the ingredient’s market history, has raised questions of fairness and transparency.

A science lab with measuring cylinders. ©Getty Images

Science shorts: NAD+, NMN, vitamin E in the spotlight

By Tingmin Koe

This round-up of new scientific findings will look at how low NAD+ level is associated with anaemia in women, Mitsubishi Life Sciences’ NMN clinical study findings, and the benefits of vitamin E for exercise recovery and PCOS.

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All